See above the fascinating presentations by Dr. Anna Wexler, Dr. Karen Rommelfanger and Jacqueline Studer on privacy and ethics during the 2019 SharpBrains Virtual Summit.
We still lack clear standards and taxonomies for neurotechnology but several initiatives are underway to anticipate and address the challenges. One important take-away is that it is important to be aspirational and pragmatic rather than “legalistic” — by considering diverse policy and industry perspectives, striving for the widest benefit with the minimum risks, and better educating users, we can enable beneficial innovation in ways that regulation alone –as important as it is– cannot.
News in Context:
- A call to action: We need the right incentives to guide ethical innovation in neurotech and healthcare
- Neuroengineering meets neuroethics to address treatment-resistant depression
- The National Academy of Medicine (NAM) shares discussion paper to help empower 8 billion minds
- Debate: What are the ethics of discouraging much-needed innovation given potential privacy concerns?
- We need to rethink neuroscience. And you can help us
- 10 highlights from the 2019 SharpBrains Virtual Summit
- Five reasons the future of brain enhancement is digital, pervasive and (hopefully) bright